Protai Raises $20M to Build an Oncology Drug Discovery Pipeline
HIT Consultant
MARCH 15, 2023
. – The round includes existing investors Grove Ventures and Pitango Healthcare and was joined by Copenhagen-based Maj Invest Equity Fund. The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data acquisition as well as increase its discovery activities via pharma partnerships.
98 
Let's personalize your content